The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dutasteride/Tamsulosin hydrochloride 0.5 mg /0.4 mg hard capsules

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/230/001

Main Information

Trade NameDutasteride/Tamsulosin hydrochloride 0.5 mg /0.4 mg hard capsules
Active SubstancesDutasteride
Tamsulosin hydrochloride
Dosage FormCapsule, hard
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/230/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA52 tamsulosin and dutasteride


License statusAuthorised
Licence Issued06/12/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0036-065-001
Interchangeable List DocumentPDF of Interchangeable List
« Back